BRAF mutation marks out specific subgroups of glioma
Background: Molecular markers including isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion have been incorporated into the World Health Organization (WHO) 2016 classification of diffuse gliomas for integrated diagnostic reporting. The prognostic relevance of BRAF mutation among the newly...
Main Authors: | Aden Ka-Yin Chan, Riki Rui-Qi Zhang, Abudumijiti Aibaidula, Zhi Feng Shi, Hong Chen, Ying Mao, Ho Keung Ng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Glioma |
Subjects: | |
Online Access: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=168;epage=174;aulast=Chan |
Similar Items
-
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01) -
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01) -
Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival
by: Peng-Fei Wang, et al.
Published: (2018-08-01) -
IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
by: Enrico Franceschi, et al.
Published: (2021-02-01) -
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
by: Qiang Zhang, et al.
Published: (2021-07-01)